LEAD - ANVISA Registration 82444370022
Access comprehensive regulatory information for LEAD in Brazil's medical device market through Pure Global AI's free database. This Risk Class II medical device is registered under ANVISA number 82444370022 and manufactured by MAGELLAN DIAGNOSTICS, INC.. The registration is held by Enzytec Biotecnologia Ltda. with validity until currently active (VIGENTE).
This page provides complete technical specifications for this device, regulatory compliance details, 5 similar products found using AI-powered semantic search, 2 companies making the same product including BEIJING DIAGREAT BIOTECHNOLOGIES CO., LTD., MAGELLAN DIAGNOSTICS, INC., and 2 recent registrations in the same technical category. Pure Global AI offers free access to over 100,000+ Brazilian medical device registrations, helping global MedTech companies navigate ANVISA regulations, identify competitors, and discover partnership opportunities efficiently.
Janaina dos Santos de Miranda
🇧🇷 Brazil Regulatory Expert
Need help with your Brazil registration?
Contact Pure Global Brazil TeamDevice Details
Registration Details
82444370022
25351178294202249
07214566000165
Company Information
Dates and Status
Aug 11, 2022
VIGENTE
09/18/2025 19:00:01
COMBINED PARAMETERS IN THE SAME PRODUCT - CLASS II
Família Controle Interno Metais em Sangue
programa nacional de controle de qualidade ltda
80155020029
Jan 02, 2023
COMBINED PARAMETERS IN THE SAME PRODUCT - CLASS II
Família Controle Interno Metais em Urina
programa nacional de controle de qualidade ltda
80155020030
Jan 02, 2023
COMBINED PARAMETERS IN THE SAME PRODUCT - CLASS II
Controle Interno Metais em Soro
programa nacional de controle de qualidade ltda
80155020025
Nov 21, 2022
COMBINED PARAMETERS IN THE SAME PRODUCT - CLASS II
N/T CONTROLE DE PROTEINA LC
SIEMENS HEALTHCARE DIAGNOSTICS PRODUCTS GMBH
10345161590
Sep 08, 2009
COMBINED PARAMETERS IN THE SAME PRODUCT - CLASS II
Lyphochek Whole Blood Metals Control
BIO-RAD LABORATORIES
80020690226
May 17, 2010